关于重新分类成人浸润性胶质瘤的一个案例。 - Suppr

Suppr

超能文献

A case for reclassifying infiltrating gliomas in adults.

作者信息

Marko Nicholas F, Weil Robert J

出版信息

J Neurooncol. 2012 Sep;109(3):587-91. doi: 10.1007/s11060-012-0928-y. Epub 2012 Jul 20.

DOI:10.1007/s11060-012-0928-y

PMID:22814861

Abstract

摘要

相似文献

A case for reclassifying infiltrating gliomas in adults.

J Neurooncol. 2012 Sep;109(3):587-91. doi: 10.1007/s11060-012-0928-y. Epub 2012 Jul 20.

Updating the grading criteria for adult diffuse gliomas: beyond the WHO2016CNS classification.

Brain Tumor Pathol. 2020 Jan;37(1):1-4. doi: 10.1007/s10014-020-00358-y.

[Pathologic anatomy of diffuse gliomas in the adult].

Soins. 2009 Mar(733):28-9.

Histoprognosis of gliomas.

Adv Tech Stand Neurosurg. 1994;21:43-76. doi: 10.1007/978-3-7091-6648-2_2.

Molecular categorisation of gliomas.

Lancet Oncol. 2015 Jul;16(7):e320. doi: 10.1016/S1470-2045(15)00073-X. Epub 2015 Jun 18.

[Classification and grading of glial tumors].

Ned Tijdschr Geneeskd. 1996 Feb 10;140(6):292-7.

Current concepts in the pathology and genetics of gliomas.

Indian J Cancer. 2009 Apr-Jun;46(2):108-19. doi: 10.4103/0019-509x.49148.

Pathology of gliomas and developments in molecular testing.

Clin Oncol (R Coll Radiol). 2014 Jul;26(7):377-84. doi: 10.1016/j.clon.2014.04.025. Epub 2014 Apr 26.

Characterization of gliomas: from morphology to molecules.

Virchows Arch. 2017 Aug;471(2):257-269. doi: 10.1007/s00428-017-2181-4. Epub 2017 Jul 4.

[Biology of gliomas].

Cancer Radiother. 2008 Nov;12(6-7):663-8. doi: 10.1016/j.canrad.2008.09.001. Epub 2008 Oct 1.

本文引用的文献

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis.

Acta Neuropathol. 2010 Dec;120(6):719-29. doi: 10.1007/s00401-010-0777-8. Epub 2010 Nov 16.

Update on molecular findings, management and outcome in low-grade gliomas.

Nat Rev Neurol. 2010 Dec;6(12):695-701. doi: 10.1038/nrneurol.2010.159. Epub 2010 Nov 2.

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.

Neurology. 2010 Jun 8;74(23):1886-90. doi: 10.1212/WNL.0b013e3181e1cf3a. Epub 2010 Apr 28.

Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion.

J Proteome Res. 2010 May 7;9(5):2610-8. doi: 10.1021/pr100054v.

Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses.

Neuro Oncol. 2010 Jul;12(7):664-78. doi: 10.1093/neuonc/nop075. Epub 2010 Feb 17.

Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues.

J Neuropathol Exp Neurol. 2009 Dec;68(12):1319-25. doi: 10.1097/NEN.0b013e3181c391be.

Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.

Genomics. 2010 Jan;95(1):16-24. doi: 10.1016/j.ygeno.2009.09.007. Epub 2009 Oct 14.

Monoclonal antibody specific for IDH1 R132H mutation.

Acta Neuropathol. 2009 Nov;118(5):599-601. doi: 10.1007/s00401-009-0595-z. Epub 2009 Oct 2.

Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression.

J Neurooncol. 2009 Dec;95(3):343-354. doi: 10.1007/s11060-009-9944-y. Epub 2009 Jul 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A case for reclassifying infiltrating gliomas in adults.

J Neurooncol. 2012 Sep;109(3):587-91. doi: 10.1007/s11060-012-0928-y. Epub 2012 Jul 20.

Updating the grading criteria for adult diffuse gliomas: beyond the WHO2016CNS classification.

Brain Tumor Pathol. 2020 Jan;37(1):1-4. doi: 10.1007/s10014-020-00358-y.

[Pathologic anatomy of diffuse gliomas in the adult].

Soins. 2009 Mar(733):28-9.

Histoprognosis of gliomas.

Adv Tech Stand Neurosurg. 1994;21:43-76. doi: 10.1007/978-3-7091-6648-2_2.

Molecular categorisation of gliomas.

Lancet Oncol. 2015 Jul;16(7):e320. doi: 10.1016/S1470-2045(15)00073-X. Epub 2015 Jun 18.

[Classification and grading of glial tumors].

Ned Tijdschr Geneeskd. 1996 Feb 10;140(6):292-7.

Current concepts in the pathology and genetics of gliomas.

Indian J Cancer. 2009 Apr-Jun;46(2):108-19. doi: 10.4103/0019-509x.49148.

Pathology of gliomas and developments in molecular testing.

Clin Oncol (R Coll Radiol). 2014 Jul;26(7):377-84. doi: 10.1016/j.clon.2014.04.025. Epub 2014 Apr 26.

Characterization of gliomas: from morphology to molecules.

Virchows Arch. 2017 Aug;471(2):257-269. doi: 10.1007/s00428-017-2181-4. Epub 2017 Jul 4.

[Biology of gliomas].

Cancer Radiother. 2008 Nov;12(6-7):663-8. doi: 10.1016/j.canrad.2008.09.001. Epub 2008 Oct 1.

本文引用的文献

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis.

Acta Neuropathol. 2010 Dec;120(6):719-29. doi: 10.1007/s00401-010-0777-8. Epub 2010 Nov 16.

Update on molecular findings, management and outcome in low-grade gliomas.

Nat Rev Neurol. 2010 Dec;6(12):695-701. doi: 10.1038/nrneurol.2010.159. Epub 2010 Nov 2.

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.

Neurology. 2010 Jun 8;74(23):1886-90. doi: 10.1212/WNL.0b013e3181e1cf3a. Epub 2010 Apr 28.

Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion.

J Proteome Res. 2010 May 7;9(5):2610-8. doi: 10.1021/pr100054v.

Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses.

Neuro Oncol. 2010 Jul;12(7):664-78. doi: 10.1093/neuonc/nop075. Epub 2010 Feb 17.

Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues.

J Neuropathol Exp Neurol. 2009 Dec;68(12):1319-25. doi: 10.1097/NEN.0b013e3181c391be.

Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.

Genomics. 2010 Jan;95(1):16-24. doi: 10.1016/j.ygeno.2009.09.007. Epub 2009 Oct 14.

Monoclonal antibody specific for IDH1 R132H mutation.

Acta Neuropathol. 2009 Nov;118(5):599-601. doi: 10.1007/s00401-009-0595-z. Epub 2009 Oct 2.

Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression.

J Neurooncol. 2009 Dec;95(3):343-354. doi: 10.1007/s11060-009-9944-y. Epub 2009 Jul 12.